A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers

NCT07143331 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants
Alzheimer Disease
Chronic Kidney Disease

Interventions

DRUG: Part 1 KS101
DRUG: Part 1 Placebo
DRUG: Part 2 with Food
DRUG: Part 2 without food
DRUG: Part 3 KS101

Sponsor

Klotho Sciences Australia Pty Ltd.